Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Julia M. Mhlaba"'
Publikováno v:
JAAD Case Reports, Vol 29, Iss , Pp 89-91 (2022)
Externí odkaz:
https://doaj.org/article/67fd25ecd7a74c04bd9e7eb82568a481
Publikováno v:
Cutis. 109
Although mycosis fungoides (MF) and Sézary syndrome (SS) commonly affect Black patients, dermatologic educational resources primarily describe the appearance of these conditions in lighter skin types. Skin of color (SoC) patients with Fitzpatrick sk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e883445068a648b1c8d906fab0f3ad4
https://doi.org/10.12788/cutis.0484
https://doi.org/10.12788/cutis.0484
Publikováno v:
Journal of drugs in dermatology : JDD. 20(7)
The United States skin of color population is increasing. Consequently, the importance of skin of color education in dermatology residency programs will continue to grow. Previous data has shown a lack of formal education on skin of color across resi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bd605ae6a229ab436b432710631e55ff
https://pubmed.ncbi.nlm.nih.gov/34232004
https://pubmed.ncbi.nlm.nih.gov/34232004
Publikováno v:
Exp Dermatol
Vitiligo is characterized by progressive loss of skin pigmentation. The search for aetiologic factors has led to the biochemical, the neurologic and the autoimmune theory. The convergence theory was then proposed several years ago to incorporate exis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ad0d072373de733bbd157dffc91ded8
https://doi.org/10.1111/exd.13677
https://doi.org/10.1111/exd.13677
Publikováno v:
JAMA dermatology. 155(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbcd97500f63b5fb7d50f71114c35752
https://pubmed.ncbi.nlm.nih.gov/30758487
https://pubmed.ncbi.nlm.nih.gov/30758487
Autor:
Emilia R. Dellacecca, Rohan Shivde, I. C. Le Poole, Roopal V. Kundu, Stephanie M. Rangel, Cormac Cosgrove, Julia M. Mhlaba
Publikováno v:
Journal of Investigative Dermatology. 141:S41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e56c2fd5f589b22df99c2c0bdfb980a9
https://doi.org/10.1016/j.jid.2021.02.252
https://doi.org/10.1016/j.jid.2021.02.252
Publikováno v:
The Dermatology Handbook ISBN: 9783030151560
A wide range of topical and systemic medications are used in the management of dermatological disorders. Within the United States, these therapies are not always FDA approved for dermatological conditions and are therefore considered “off-label”
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f373a918042e8af91fa1df1f1b57002
https://doi.org/10.1007/978-3-030-15157-7_8
https://doi.org/10.1007/978-3-030-15157-7_8
